Systemic Mastocytosis and Cardiovascular Risk

Systemic Mastocytosis and Cardiovascular Risk - SMaCR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38215

Enrollment

100

Registered

2014-01-22

Start date

2014-04-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis cardiovascular disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age older than 18 years Diagnosed with systemic mastocytosis according to WHO criteria Given informed consent

Exclusion criteria

Exclusion criteria: Age younger than 18 years No informed consent

Design outcomes

Primary

Measure	Time frame
The main study parameter is the extent of atherosclerosis determined by C-IMT and carotid plaques and presence of cardiovascular risk factors (hypertension, diabetes, dyslipidemia, overweight/obesity)	—

Countries

Netherlands

Outcome results